The application of 5 to 25 nM FK228 for 24 h reduced JAK2 in K562 cells, which belong to the CML cell type within the group of MPNs (Supplementary Fig. 3k). Here, JAK2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.